Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,578
archived clinical trials in
Skin and Soft Tissue Infections

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
1971
mi
from 98109
Cincinnati, OH
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
1971
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
2006
mi
from 98109
Columbus, OH
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study center
mi
from 98109
Clackamas, OR
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study center
mi
from 98109
Clackamas, OR
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
1666
mi
from 98109
Austin, TX
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
1666
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study center
mi
from 98109
Dallas, TX
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study center
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
1787
mi
from 98109
San Antonio, TX
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Spokane, WA
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
1062
mi
from 98109
San Diego, CA
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
1062
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
New York, NY
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Fair Lawn, NJ
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Fair Lawn, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Hershey, PA
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
1904
mi
from 98109
Ann Arbor, MI
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
1904
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Durham, NC
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Tampa, FL
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated:  12/31/1969
Study Center
mi
from 98109
Vienna,
Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema
Status: Enrolling
Updated: 12/31/1969
Study Center
mi
from 98109
Vienna,
Click here to add this to my saved trials
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
A Double Blinded Randomized Controlled Trial for the Management of Pediatric Community Acquired Skin Abscesses - To Treat or Not to Treat With Antibiotics
Status: Enrolling
Updated:  12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
A Double Blinded Randomized Controlled Trial for the Management of Pediatric Community Acquired Skin Abscesses - To Treat or Not to Treat With Antibiotics
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2 up to and Including 13 Years of Age
Status: Enrolling
Updated:  12/31/1969
Portland Clinical Research/AAIM Care, LLC
mi
from 98109
Portland, OR
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2 up to and Including 13 Years of Age
Status: Enrolling
Updated: 12/31/1969
Portland Clinical Research/AAIM Care, LLC
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2 up to and Including 13 Years of Age
Status: Enrolling
Updated:  12/31/1969
UIA FN Plzen ( Institute of Immunology and Allergology), Faculty Hospital Plzen
mi
from 98109
Plzen,
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2 up to and Including 13 Years of Age
Status: Enrolling
Updated: 12/31/1969
UIA FN Plzen ( Institute of Immunology and Allergology), Faculty Hospital Plzen
mi
from 98109
Plzen,
Click here to add this to my saved trials
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
A Case Series to Investigate the Safety and Efficacy of Weekly Application of Dehydrated Human Amnion/Chorion Membrane (dHACM) in the Treatment of Pressure Ulcers
Status: Enrolling
Updated:  12/31/1969
Shepherd Spine Center
mi
from 98109
Atlanta, GA
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
A Case Series to Investigate the Safety and Efficacy of Weekly Application of Dehydrated Human Amnion/Chorion Membrane (dHACM) in the Treatment of Pressure Ulcers
Status: Enrolling
Updated: 12/31/1969
Shepherd Spine Center
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries
A Randomized Controlled Pilot Study Comparing Air Fluidized Therapy (AFT) to a Continuous Low Pressure (CLP) Low Air Loss (LAL) Support Surface in the Treatment of Stage 3 or 4 Pressure Injuries
Status: Enrolling
Updated:  12/31/1969
Noland Health Anniston
mi
from 98109
Anniston, AL
AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries
A Randomized Controlled Pilot Study Comparing Air Fluidized Therapy (AFT) to a Continuous Low Pressure (CLP) Low Air Loss (LAL) Support Surface in the Treatment of Stage 3 or 4 Pressure Injuries
Status: Enrolling
Updated: 12/31/1969
Noland Health Anniston
mi
from 98109
Anniston, AL
Click here to add this to my saved trials
AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries
A Randomized Controlled Pilot Study Comparing Air Fluidized Therapy (AFT) to a Continuous Low Pressure (CLP) Low Air Loss (LAL) Support Surface in the Treatment of Stage 3 or 4 Pressure Injuries
Status: Enrolling
Updated:  12/31/1969
Noland Health
mi
from 98109
Birmingham, AL
AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries
A Randomized Controlled Pilot Study Comparing Air Fluidized Therapy (AFT) to a Continuous Low Pressure (CLP) Low Air Loss (LAL) Support Surface in the Treatment of Stage 3 or 4 Pressure Injuries
Status: Enrolling
Updated: 12/31/1969
Noland Health
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Advanced Wound Care Center at Yavapai Regional Medical Center
mi
from 98109
Prescott Valley, AZ
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Advanced Wound Care Center at Yavapai Regional Medical Center
mi
from 98109
Prescott Valley, AZ
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Jupiter Medical Center
2679
mi
from 98109
Jupiter, FL
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Jupiter Medical Center
2679
mi
from 98109
Jupiter, FL
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
West Gables Rehab Hospital
mi
from 98109
Miami, FL
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
West Gables Rehab Hospital
mi
from 98109
Miami, FL
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Institute for Advanced Wound Healing; Northshore Specialty Hospital
mi
from 98109
Covington, LA
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Institute for Advanced Wound Healing; Northshore Specialty Hospital
mi
from 98109
Covington, LA
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Wound Care Associates, LLC.
mi
from 98109
Hammond, LA
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Wound Care Associates, LLC.
mi
from 98109
Hammond, LA
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Opelousas General Hospital Wound Center
mi
from 98109
Opelousas, LA
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Opelousas General Hospital Wound Center
mi
from 98109
Opelousas, LA
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Saint Louis Foot and Ankle
mi
from 98109
Saint Louis, MO
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Saint Louis Foot and Ankle
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
CentraState Medical Center
2404
mi
from 98109
Freehold, NJ
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
CentraState Medical Center
2404
mi
from 98109
Freehold, NJ
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Robert Wood Johnson Hamilton
mi
from 98109
Hamilton, NJ
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Robert Wood Johnson Hamilton
mi
from 98109
Hamilton, NJ
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Southampton Hospital
mi
from 98109
Southampton, NY
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Southampton Hospital
mi
from 98109
Southampton, NY
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Sacred Heart Hospital
2337
mi
from 98109
Allentown, PA
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Sacred Heart Hospital
2337
mi
from 98109
Allentown, PA
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Harrisburg Foot and Ankle Center
2285
mi
from 98109
Harrisburg, PA
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Harrisburg Foot and Ankle Center
2285
mi
from 98109
Harrisburg, PA
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Greensville Health System
mi
from 98109
Greenville, SC
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Greensville Health System
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated:  12/31/1969
Meriter Hospital Inc., DBA: UnityPoint Health Heart and Vascular Institute
mi
from 98109
Madison, WI
The RESPOND Registry
Real-World Effectiveness Study of PuraPly™ AM on Wounds
Status: Enrolling
Updated: 12/31/1969
Meriter Hospital Inc., DBA: UnityPoint Health Heart and Vascular Institute
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Er Med, Llc
mi
from 98109
Montgomery, AL
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Er Med, Llc
mi
from 98109
Montgomery, AL
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Arrowhead Regional Medical Center
973
mi
from 98109
Colton, CA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Arrowhead Regional Medical Center
973
mi
from 98109
Colton, CA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
University of California, Los Angeles, School of Medicine
959
mi
from 98109
Los Angeles, CA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
University of California, Los Angeles, School of Medicine
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
University of California San Diego Mecial Center
mi
from 98109
San Diego, CA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
University of California San Diego Mecial Center
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Christiana Hospital, Department of Emergency Medicine
mi
from 98109
Newark, DE
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Christiana Hospital, Department of Emergency Medicine
mi
from 98109
Newark, DE
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
2322
mi
from 98109
Washington,
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
2527
mi
from 98109
Tampa, FL
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Georgia Health Sciences University
2299
mi
from 98109
Augusta, GA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Georgia Health Sciences University
2299
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Dekalb Medical
2182
mi
from 98109
Decatur, GA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Dekalb Medical
2182
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
University Consultants in Allergy and Immunology
1733
mi
from 98109
Chicago, IL
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
University Consultants in Allergy and Immunology
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital and Medical Center
1734
mi
from 98109
Chicago, IL
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital and Medical Center
1734
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated:  12/31/1969
Ochsner Clinic Foundation
2095
mi
from 98109
New Orleans, LA
Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic Foundation
2095
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials